EuropeanBiotechnology

Science & Industry NewsDecember 2012

SPECIAL

29_EBN12_12_SPECIAL_BIO-Regions_tg.indd 27 06.12.2012 12:30:28 Uhr

Why attend?The patent cliff and an increasingly payer-driven environment are problems for the life sciences industry. Specialised treat-ments have thus become a critical asset for pharma. Drug diagnostics combinations – so called companion diagnostics – offer companies the ability to develop targeted drugs with the potential for greater effi cacy, accelerated regulatory approval and better reimbursement. Thus, developing treatments without suitable diagnostics has become an expensive form of Russian roulette. But, this joint process is complex. The challenges have created new forms of cooperation between pharma, biotechs and diagnostics service companies and resources needed to cope with giant amounts of data. The reward is huge: analysts forecast new billion dollar markets.

This BIOCOM Event offers a unique opportunity to gain insight into the converging strategies of pharma and diagnostics com-panies. Leading experts in the fi eld of biomarkers, diagnostics, IT and drug development will share their knowledge on how to successfully develop and market new concepts.

Please register now at www.biocom.de/events/IP or send an email to events@biocom.de. Restricted Capacity!

8 February 2013, 9:30 a.m., Embassy of the Netherlands in Berlin, Germany

Organisation: BIOCOM AG | Lützowstraße 33–36 | 10785 Berlinwww.biocom.de | events@biocom.de | Tel. +49 (0)30 264921-53 | Fax +49 (0)30 264921-66

Supporting Partners: Media Partner:

© N

ethe

rland

s Em

bass

y B

erlin

, Chr

istia

n R

icht

er

Sponsors:

EuropeanBiotechnology

NET WORK

6th-IP-Ad_210x275.indd 87 05.12.2012 17:47:14 Uhr30_EBSIN12_12_6th-IP.indd 1 05.12.2012 17:49:39 Uhr

Euro Biotech News

Bioregions: becoming the next major hub

New York/New Jersey

Seattle

San Francisco

Los Angeles

San Diego

MontrealBoston

PhiladelphiaBaltimore/Washington DCResearch Triangle NC

Toronto

Sao Paulo

Belo Horizonte/Rio de Janeiro

Cape Town

BangaloreHyderabad

Dunedin

Brisbane

Sydney

Melbourne

Singapore

Hong Kong

Hokkaido

Tokio

Kansai

Shanghai

Bejing

New Delhi

Israel

HelsinkiStockholm/Uppsala

BIO.NRWM4

Scanbalt

Glasgow/Edinburgh

Sophia-AntipolisBioAlpsBiovalleyParis

BioWinDublin

One Nucleus

Source: William Hoffman, MBBNet, University of Minnesota, Minneapolis, MN, USA; Figure: BIOCOM AG

31_EBSIN12_12_Special_intro_tg.indd 31 06.12.2012 12:33:22 Uhr

Euro Biotech News

Advancing life science at the heart of Europe

© S

tand

orta

gent

ur T

irol

32_34_EBSIN12_12_Special_Austria_tg.indd 32 06.12.2012 12:34:04 Uhr

Life Sciences.Living Research. Berlin. Brandenburg.

A vibrant network.

Berlin-Brandenburg is one of Europe’s leading locations for the

Life Sciences. It is also an R&D capital that magnetically attracts

the world’s top scientists. Here you’ll find attractive subsidy condi-

tions, close linkages between business and science, the highest

concentration of R&D in Europe, a dynamic startup scene and a

multifaceted entrepreneurial environment made up of more than

500 pharmaceutical, biotech and medical engineering compa-

nies. Come discover this one-of-a-kind landscape for scientists

and entrepreneurs.

www.biotop.de/business

210x275_EBN_Biotech_en_Arial_rz.indd 5 05.06.12 11:5033_EBSIN12_12_ZAB-BerlinPartner.indd 1 06.12.2012 12:34:41 Uhr

Euro Biotech News

© urban picnic

© R

iegl

er R

iew

e Ar

chite

kten

32_34_EBSIN12_12_Special_Austria_tg.indd 34 06.12.2012 14:56:33 Uhr

35_EBSIN12_12_BIONRW.indd 1 07.12.2012 10:59:53 Uhr

Euro Biotech News

Clusters – where will they go from here?

36_EBSIN12_12_Special_CEBR.indd 36 05.12.2012 17:52:43 Uhr

ecoplus technopols. opening up access to know-how and technology.

ecoplus. The Business Agency of Lower AustriaNiederösterreichring 2, Haus A, 3100 St. Pölten

ecoplus Technopols connect the business world to top educational facilities and research institutes of international renown. In Krems, research is focused on biotechnology and regenerative medicine, and in Tulln, on agrobiotechnology and environmental biotechnology. In Wiener Neustadt, focus lies on materials, surface technology, process and chemical engineering, medical technology, sensor technology and actuators.

www.ecoplus.at

The Technopol Program of Lower Austria is co-financed by the European Regional Development Fund (ERDF).

ECO_Anzeige_210x290_Technopole_engl.indd 1 07.03.12 16:27

ecoplus technopols. opening up access to know-how and technology.

ecoplus. The Business Agency of Lower AustriaNiederösterreichring 2, Haus A, 3100 St. Pölten

ecoplus Technopols connect the business world to top educational facilities and research institutes of international renown. In Krems, research is focused on biotechnology and regenerative medicine, and in Tulln, on agrobiotechnology and environmental biotechnology. In Wiener Neustadt, focus lies on materials, surface technology, process and chemical engineering, medical technology, sensor technology and actuators.

www.ecoplus.at

The Technopol Program of Lower Austria is co-financed by the European Regional Development Fund (ERDF).

ECO_Anzeige_210x290_Technopole_engl.indd 1 07.03.12 16:27

ecoplus technopols. opening up access to know-how and technology.

ecoplus. The Business Agency of Lower AustriaNiederösterreichring 2, Haus A, 3100 St. Pölten

ecoplus Technopols connect the business world to top educational facilities and research institutes of international renown. In Krems, research is focused on biotechnology and regenerative medicine, and in Tulln, on agrobiotechnology and environmental biotechnology. In Wiener Neustadt, focus lies on materials, surface technology, process and chemical engineering, medical technology, sensor technology and actuators.

www.ecoplus.at

The Technopol Program of Lower Austria is co-financed by the European Regional Development Fund (ERDF).

ECO_Anzeige_210x290_Technopole_engl.indd 1 07.03.12 16:2737_EBSIN12_12_ecoplus.indd 1 07.12.2012 11:00:52 Uhr

Euro Biotech News

An emerging hub with biotech know-how

38_EBSIN12_12_Special_Lithuania.indd 38 05.12.2012 17:53:07 Uhr

In 2013 meet LISA at >> MEDTEC Europe // Stuttgart // February 26-28 BIO-Europe Spring // Barcelona // March 11-13 BIO International Convention // Chicago // April 22-25 CPhI Worldwide // Frankfurt // October 22-24BIO-Europe // Vienna // November 4-6 Medica // Duesseldorf // November 20-23

Advancing Austrian life science //at the heart of Europe

www.LifeScienceAustria.at

Ins_210x275_MESSEN_2013.indd 1 10.07.12 14:5039_EBSIN12_12_LISA.indd 1 06.12.2012 12:36:51 Uhr

Euro Biotech News

HealthCapital Berlin-Brandenburg

© k

aise

rwet

ter /

Nob

ert M

icha

lke

40-41_EBSIN12_12_Special_Biotop_tg.indd 40 06.12.2012 12:37:38 Uhr

Euro Biotech News

40-41_EBSIN12_12_Special_Biotop_tg.indd 41 05.12.2012 17:57:54 Uhr